Drug Trial Radar · NCT04925934
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
Last checked: Nov 19, 2026Latest source record: Jul 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
214
Actual
Start
May 28, 2021
Primary completion
May 16, 2023
Study completion Jun 9, 2023
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Jun 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus in approximately 195 participants. The study duration will be 48 weeks, with a safety follow-up through week 56.There will be 3 parallel arms - 2 active treatment and 1 placebo.
Conditions
- Lupus Erythematosus, Systemic
Interventions
VIB7734Drug
VIB7734
PlaceboOther
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Achieving a BILAG-2004 Index-based Combined Lupus Assessment (BICLA) Response and an OGC Dose ≤ 7.5 mg/Day and ≤ Baseline Dose of Prednisone or Equivalent at Week 48Time frame: Week 48
Locations
67 sites in 11 countries. Site status is shown where the registry gives one.
Inland Rheumatology Clinical Trials Incorporated
Upland, California
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida
Millennium Research
Ormond Beach, Florida
IRIS Research and Development LLC
Plantation, Florida
Clinical Research of West Florida Inc - Tampa
Tampa, Florida
Emory University School of Medicine
Atlanta, Georgia
Bluegrass Community Research Inc
Lexington, Kentucky
NYU Langone Ambulatory Care Brooklyn Heights
Brooklyn, New York
Feinstein Institute For Medical Research
Manhasset, New York
SUNY Upstate Medical Center
Syracuse, New York
DJL Clinical Research
Charlotte, North Carolina
Paramount Medical Research and Consulting LLC
Middleburg Heights, Ohio
Tekton Research Inc
Austin, Texas
Precision Comprehensive Clinical Research Solutions
Colleyville, Texas
Metroplex Clinical Research Center
Dallas, Texas
Southwest Rheumatology Research, LLC
Mesquite, Texas
Spectrum Medical, Inc
Danville, Virginia
Consultorios Médicos Dr. Doreski
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Clínica Adventista Belgrano
Estomba, Buenos Aires, Argentina
Framingham Centro Médico
La Plata, Buenos Aires, Argentina
Instituto CER S.A
Quilmes, Buenos Aires, Argentina
Instituto de Investigaciones Clinicas Quilmes SRL
Quilmes, Buenos Aires, Argentina
Centro Medico Privado de Reumatologia
San Miguel de Tucumán, Tucumán Province, Argentina
Consultorio de Investigaciones Reumatologicas
San Miguel de Tucumán, Tucumán Province, Argentina
Athens General Hospital 'G Gennimatas
Athens, Greece
Laiko General Hospital of Athens
Athens, Greece
University General Hospital of Larissa
Larissa, Greece
Kianous Stavros
Thessaloniki, Greece
Krishna Institute of Medical Sciences
Secunderabad, Andhra Pradesh, India
AES - AS - Panchshil Hospital - Ahmedabad
Ahmedabad, Gujarat, India
AES - AS - Unity Trauma Center and ICU - Unity Hospital - Surat
Surat, Gujarat, India
AES - AS - Sushruta Multispeciality Hospital & Research Center Pvt Ltd - Hubli
Hubli, Karnataka, India
Jasleen Hospital
Nagpur, Maharashtra, India
AMAF Clinical Research,S.C.
Distrito Federal, Mexico
Clinica de Investigacion en Reumatologia y Obesidad
Guadalajara, Mexico
Centro de Estudios de Investigacion Basica Y Clinica SC
Jalisco, Mexico
Consultorio de Reumatologia
Mexico City, Mexico
Centro de Investigación en Artritis y Osteoporosis
Mexicali, Estado de Baja California, Mexico
Morales Vargas Centro de Investigacion SC
León, Guanajuato, Mexico
Bioclinica - Centro Integral En Reumatologia Sociedad Anónima de Capital Variable
Guadalajara, Jalisco, Mexico
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.